Retatrutide 40mg

Synedica Retatrutide 40mg represents an advanced triple-agonist research compound targeting GLP-1, GIP, and Glucagon receptor pathways simultaneously. Formulated to high analytical standards, this product provides researchers with maximum purity and consistency for laboratory studies.

 

Technical Specifications

• Compound Name: Retatrutide

• Target Pathways: GLP-1 / GIP / Glucagon Receptor Agonist

• Format: Available in Lyophilized Vial or Precision Synedica Pen Kit

• Concentration: 40mg total active compound per unit

• Purity Rating: ≥99.0% (HPLC Verified)

• Storage: Store at -20°C upon receipt; stable at ambient temperatures during transit.

 

Analytical Verification & Quality Control

Every batch of Retatrutide 40mg from Synedica is independently tested using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry to verify identity and exact purity standards.

 

Frequently Asked Questions

How is the 40mg format supplied? We supply this compound in standard lyophilized research vials for manual reconstitution, as well as integrated pen kit options for precise laboratory administration.

 

Where can I find the Certificate of Analysis (COA)? Each unit features a lot-specific batch number matching the third-party lab documentation available in our online repository.